Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA approves Botox to treat specific form of urinary incontinence

The U.S. Food and Drug Administration today approved Botox ( onabotulinumtoxinA ) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.

REFINE

medications
- - Remove Botox filter (-) Remove Botox filter Botox
conditions
- - Remove Neuromuscular Disease filter (-) Remove Neuromuscular Disease filter Neuromuscular Disease
    Remove Multiple Sclerosis filter (-) Remove Multiple Sclerosis filter Multiple Sclerosis
  - Apply Incontinence filter Incontinence (1) Apply Incontinence filter
    Apply Overactive Bladder OAB filter Overactive Bladder OAB (1) Apply Overactive Bladder OAB filter
  - Apply Trauma filter Trauma (1) Apply Trauma filter